Clinical Trials
Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform
The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings PRS a potential access to 40 sites and a 25 M patient population, opening up...
Clinical Trials
Renova Therapeutics selects Worldwide Clinical Trials as its CRO for RT-100 AC6 gene transfer
Renova Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes. Announced that it has selected Worldwide Clinical Trials as its CRO for a Phase 3 study of RT-100 AC6...
Clinical Trials
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye
Sun Pharma (SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies), announced successful Phase 3 confirmatory clinical trial results for Seciera™ (cyclosporine A, 0.09% ophthalmic solution). For the treatment...
Clinical Trials
Protalix BioTherapeutics Announces Positive results from Phase II Clinical Trial of alidornase alfa
Protalix BioTherapeutics Inc announced positive interim results from the Company’s phase II clinical trial of alidornase alfa for the treatment of Cystic Fibrosis (CF) for the first 13 CF patients enrolled in the study. Fifteen...
Articles
Clinical research data sharing promises new cures and treatments
Clinical research generates extensive amounts of data, yet most of it is siloed or generally unavailable to a larger pool of willing potential researchers.
If this data were liberated to the masses, we would venture into a world of endless...
Clinical Trials
Allergan and Ironwood Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2)
Ronwood Pharmaceuticals and Allergan plc announced topline data from a Phase IIb clinical trial evaluating an investigational linaclotide colonic release-2 (CR2) formulation in adult patients with irritable bowel syndrome with constipation (IBS-C). The data showed that...
Clinical Trials
Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases
Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, and OSE Immunotherapeutics SA announced the signing of two service agreements that provide OSE Immunotherapeutics with access to high performance research...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















